Tracking Drug-Resistant Streptococcus pneumoniae in Oregon: An Alternative Surveillance Method
1999

Tracking Drug-Resistant Streptococcus pneumoniae in Oregon

Sample size: 1290 publication Evidence: moderate

Author Information

Author(s): Arthur E. Chin, Katrina Hedberg, Paul R. Cieslak, Maureen Cassidy, Karen R. Stefonek, David W. Fleming

Primary Institution: Oregon Health Division

Hypothesis

Can aggregating existing hospital antibiograms provide community-specific antimicrobial susceptibility data for Streptococcus pneumoniae?

Conclusion

Antibiogram data can provide accurate, community-specific drug-resistant S. pneumoniae data in Oregon.

Supporting Evidence

  • 86% of active surveillance isolates were susceptible to penicillin.
  • 84% of aggregated isolates used by hospitals were susceptible to penicillin.
  • Statistical comparisons showed no significant differences in susceptibility estimates between the two methods.

Takeaway

This study looked at whether hospitals' existing data on bacteria could help understand how many germs are resistant to antibiotics in the community.

Methodology

The study compared active surveillance data with aggregated antibiogram data from hospital laboratories.

Potential Biases

Antibiogram data may have been influenced by multiple isolates from a single patient.

Limitations

The active surveillance system had a case-isolate recovery rate of 67%, and antibiogram data may have included isolates from non-Portland-area residents.

Participant Demographics

Portland Tri-County area residents, population 1.2 million.

Statistical Information

Confidence Interval

95% CI = 80% to 91%

Statistical Significance

p>0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication